EIP European Immunogenicity Platform

TLDR

European Immunogenicity Platform is a central meeting place for biopharmaceutical companies and scientific experts working in immunogenicity research and assessment.

Overview

Founded in 2007, EIP acts as a hub for European biopharmaceutical companies and scientific experts in immunogenicity, building know-how through industry-academia interaction. The platform represents companies and professionals involved in immunogenicity assessment tools and research, and engages with authorities on immunogenicity guidelines and regulatory matters.